$3M Boost for PetVivo’s Veterinary Tech | Spring & PRP Therapies Expand

Jun 20, 2025

Investors in animal health tech, take note: PetVivo Holdings secures a $3 million institutional investment to accelerate its flagship products—Spring and PrecisePRP. As part of their $5M Series B round, this latest funding round helps expand the reach of their groundbreaking injectable osteocushion and PRP therapies for pets. With CEO John Lai calling it a “major milestone,” this move strengthens PetVivo’s position in the fast-growing veterinary therapeutics space.

Stay tuned as we track the final $1M closing by June 26 and the impact of this funding on animal health innovation.

#PetVivo #VeterinaryTech #AnimalHealth #StartupFunding #BiotechInvesting #SeriesBRound #PetCareInnovation #PRPTherapy #SpringInjectable #BiomedicalNews #NewsOut #VetTherapeutics #AnimalHealthInvestment